Fumaric Acid

Fumaric Acid

SCHEMBL7400191

COCCN1CCC(CN(C(=O)O)c2ccccc2-c2nc(C)no2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 1/20 0.36
PIK3CD known ✓ O00329 1/20 0.36
PIK3R2 known ✓ O00459 1/20 0.36
PIK3CA known ✓ P42336 1/20 0.36
PIK3CB known ✓ P42338 1/20 0.36
PIK3CG known ✓ P48736 1/20 0.36
PIK3R5 known ✓ Q8WYR1 1/20 0.36
PIK3R3 known ✓ Q92569 1/20 0.36
S1PR1 known ✓ P21453 1/20 0.34
ACKR3 P25106 2/20 0.40
HCRTR1 O43613 6/20 0.36
HCRTR2 O43614 6/20 0.36
GSK3B P49841 3/20 0.36
BCHE P06276 1/20 0.34
CARM1 Q86X55 1/20 0.34
SMYD3 Q9H7B4 1/20 0.34
POLB P06746 1/20 0.34
LIPG Q9Y5X9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL7400186 1.00 ACKR3 (0.40) ACKR3HCRTR1HCRTR2KMT2AGSK3B
SCHEMBL7397803 0.96 ACKR3 (0.42) ACKR3HCRTR1HCRTR2KMT2AGSK3B
Maleic Acid SCHEMBL7399487 0.86 KDM1A (0.38) ACKR3HCRTR1HCRTR2KMT2A
SCHEMBL7403466 0.85 ACKR3 (0.40) ACKR3HCRTR1HCRTR2KMT2ACARM1
Fumaric Acid SCHEMBL7399492 0.85 HCRTR1 (0.33) ACKR3HCRTR1HCRTR2KMT2ABCHE
Maleic Acid SCHEMBL7399489 0.85 HCRTR1 (0.33) ACKR3HCRTR1HCRTR2KMT2ABCHE
Maleic Acid SCHEMBL7392185 0.85 HCRTR1 (0.36) HCRTR1HCRTR2KMT2APIK3CDPIK3CG
Fumaric Acid SCHEMBL7392191 0.85 HCRTR1 (0.36) HCRTR1HCRTR2KMT2APIK3CDPIK3CG
Fumaric Acid SCHEMBL7398829 0.84 SMN1; SMN2 (0.35) ACKR3HCRTR1HCRTR2KMT2A
Maleic Acid SCHEMBL7398825 0.84 SMN1; SMN2 (0.35) ACKR3HCRTR1HCRTR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0972773-A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates GLAXO GROUP LIMITED (GB) 2000-01-19 EP disclosed
EP-0640081-B1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT4 ANTAGONISTS GLAXO GROUP LTD (GB) 2000-01-12 EP disclosed
US-5618827-A TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS GLAXO GROUP LIMITED (GB) 1997-04-08 US disclosed
EP-0640081-A1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS GLAXO GROUP LIMITED (GB) 1995-03-01 EP disclosed
WO-1993020071-A1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS GLAXO GROUP LIMITED (GB) 1993-10-14 WO disclosed